company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2172000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1651000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6701000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6701000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39258000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8230000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31138000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31138000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,662000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,662000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,662000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37177000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,325000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1938000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1375000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6548000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6548000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3355000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13004000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9554000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9554000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,811000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,811000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,811000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3817000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,208000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1860000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,276000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6799000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6799000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-434000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33844000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27709000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6569000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6569000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,234000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,234000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,234000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13134000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1846000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6700000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2223000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2223000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-511000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1505000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26515000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60776000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60776000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60776000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,83052000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,98000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2164000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1032000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11181000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11169000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-384000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6190000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5794000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5794000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-571000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5114000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4543000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4543000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-832000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,56253000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56253000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,22000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8051000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,70644000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,135085000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,135073000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-926000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8195000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7269000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7269000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,571000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,376000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,947000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,947000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,143289000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12823000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12823000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2166000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10585000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25410000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25410000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-592000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8625000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8033000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8033000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-559000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1191000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,632000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,632000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16745000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,190000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1849000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2460000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12407000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12407000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1073000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5720000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1494000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5287000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5287000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2121000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2121000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2121000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15573000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,310000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39560000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39560000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,878000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30556000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5000000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13126000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13126000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7950000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8080000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6920000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,208957000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,208957000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,208957000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,186721000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42333000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42333000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,601000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10227000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7311000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45850000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45850000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4133000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4560000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3725000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4968000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4968000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2888000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10509000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13397000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13397000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54279000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,64237000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64237000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,740000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10701000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1772000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56048000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56048000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6235000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2160000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2160000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6235000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6235000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6186000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19524000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25710000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25710000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,820000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18275000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18275000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,911000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12986000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23288000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,55460000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,55460000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6211000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2640000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2880000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5971000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5971000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5180000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5180000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5180000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54669000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37057000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37057000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1086000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17191000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11599000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7181000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7181000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3450000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9250000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5240000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4960000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12980000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12980000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7815000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7815000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7815000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12346000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,41422000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41422000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1199000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12035000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9099000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45557000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45557000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2001000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3840000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3600000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2241000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2241000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7358000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7580000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14938000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14938000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58254000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,63484000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63484000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1215000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19571000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5661000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,89931000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,89931000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2257000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1920000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1920000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2257000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2257000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5531000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27297000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32828000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32828000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,120502000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10368000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4147000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4147000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1410000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23490000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-33966000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4919000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4919000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1119000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2640000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2640000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1119000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1119000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18226000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17461000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35687000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35687000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29649000.0
